Clinical TrialsSearch results
Number of results: 395
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Clinical Study of DTX301 AAV- Mediated Gene Transfer for Ornithine Transcarbamylase(OTC) Deficiency
- late-onset Ornithine Transcarbamylase (OTC) Deficiency
- Kajiwara Makoto
- 2023-01-30
Recruiting
- Characteristics of logical reasoning skills and intervention effects in children with developmental disabilities: a computer based program approach
- Autism spectrum disorder
- Kotegawa Kohei
- 2022-08-26
Recruiting
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis
- Colitis, Ulcerative
- Shikamura Mitsuhiro
- 2021-05-31
Recruiting
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease
- Crohn's Disease
- Shikamura Mitsuhiro
- 2021-06-01
Recruiting
- A Study of Teclistamab in Combination with Daratumumab Subcutaneously (SC) (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants with Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Nishikawa Kazuk
- 2022-03-02
Recruiting
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
- Colitis, Ulcerative
- Nakama Takahiro
- 2024-02-15
Recruiting
- A Phase 3 Study of Adeno-associated Virus Serotype 8-mediated Gene Transfer of Glucose-6-phosphatase in Patients With Glycogen Storage Disease Type Ia
- Glycogen storage disease type Ia
- Kajiwara Makoto
- 2024-03-15
Recruiting
- A clinical study of non-invasive diagnostic criteria for detrusor underactivity
- UAB syndrome
- Yoshida Masaki
- 2023-04-30
Recruiting
- [M24-209] An Open-Label Phase 1b Study Evaluating the Safety and Efficacy of ABBV-383 in AL Amyloidosis
- Immunoglobulin Light Chain (AL) Amyloidosis
- Satomi Natsuko
- 2024-03-28
Recruiting
- [M23-700] Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants with Moderate to Severe Rheumatoid Arthritis
- Rheumatoid Arthritis
- Otani Tetsuya
- 2023-06-18